The New Immunotherapy Protocol. Pindolol
Pindolol, like sulindac, are inexpensive generic drugs that have a tremendous potential for the treatment of cancer and leukemia. Yet the medical profession has ignored their therapeutic potential.
Pindolol is an anti-hypertensive drug that blocks both beta 1 and 2 receptors. These receptors are activated by adrenaline and noradrenaline to produce cyclic AMP. As I have written about extensively, cyclic AMP promotes almost total immunosuppression and the direct growth of cancer cells.
Two years ago, I wrote an essay on a new study which found that behavioral stress promoted the growth and development of ovarian cancer cells in mice. Stress increases the level of adrenaline, etc. in the tumor mass which promotes the synthesis and secretion of VEGF, the metastatic growth factor, and other growth factors. Read the essay and especially the article abstract itself. It speaks for itself.
http://grouppekurosawa.typepad.com/grouppe_kurosawa_natural_/2006/07/chronic_stress_.html
Many people, including Anna, have sworn to me that their cancers did not grow appreciably until they experienced periods of prolonged psychological stress. There isn't a cancer/leukemia patient in the world that does not exprience psychological stress.
Your average anti-anxiety pill will NOT help you. You need a combined beta 1/2 blocker. It would be advantageous to also block the secretion of adrenaline and noradrenaline into the blood and tumor mass. ONLY the drug pindolol can accomplish this task. One of the members found that WalMart sells a 90 day supply of pindolol for $10.
The diagnosis of cancer or leukemia causes severe psychological stress. Surgery, radiation and chemotherapy all cause physical stress. This stress works against the efficacy of the treatment protocols by increasing the level of adrenaline and noradrenaline in the blood and tumor mass. It doesn't make any difference if the increase in cellular cyclic AMP is mediated by adrenaline, noradrenaline or the dreaded PGE2 prostaglandin. The increased synthesis of cyclic AMP in cancer and immune cells must be inhibited or the therapy will fail.
Stay tuned...
Grouppe Kurosawa, Medicine in the Public Interest
Comments